Crane Company Earnings Call Highlights Growth Momentum
Crane Company ((CR)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Crane Company Earnings Call Signals Confidence Despite Near-Term Headwinds
Crane Company’s latest earnings call struck an overall upbeat tone, underscoring strong operational execution, robust cash generation and a growing backlog that supports multi-quarter visibility. Management highlighted double-digit earnings growth, standout performance in Aerospace & Advanced Technologies (AAT), and strategic acquisitions that are tracking better than initially planned. While they acknowledged pockets of weakness in Process Flow Technologies (PFT), temporary margin dilution from acquisitions, and higher interest costs, the overriding message was that structural strengths and prudent capital allocation outweigh cyclical and integration-related pressures.
Strong EPS Growth Driven by Productivity and Pricing
Crane delivered adjusted EPS of $1.53 in the fourth quarter, a 21% increase year over year, with full-year adjusted EPS up 24%. Management credited the performance to a combination of productivity initiatives, disciplined pricing and healthy volumes, rather than one-off boosts. This quality of earnings narrative is important for investors, as it suggests the company’s profit gains are rooted in sustainable operational improvements, even as some end markets soften.
Solid Top-Line Trends and a Growing Backlog
Core sales grew 5.4% in the quarter, and Crane’s core FX-neutral backlog expanded 14% year over year, giving the company strong visibility over the coming quarters. Management emphasized that the larger backlog is not just inflationary, but reflects underlying demand in key businesses, particularly AAT. This backlog growth provides a cushion against macro uncertainty and gives Crane a clearer runway to plan production, pricing, and capacity investments.
Aerospace & Advanced Technologies Continues to Outperform
Aerospace & Advanced Technologies again led the way, with sales reaching $272 million, up 15% year over year, almost entirely organically. Backlog in the segment climbed to just over $1 billion, a 25% increase, underscoring sustained demand. OEM sales were especially strong, with overall OEM up 23%, driven by commercial OEM growth of 27% and military OEM up 18%. Segment margins expanded 50 basis points to 23.6%, showing that Crane is not only growing in aerospace but doing so profitably, benefitting from content wins and favorable mix.
PFT Margin Expansion Even as Revenues Trough
In Process Flow Technologies, sales were essentially flat at $309 million, but adjusted operating margin still expanded to 22%, a 170 basis point improvement. This margin performance in the face of softer revenues reflects tight cost control and pricing discipline. Management framed this as evidence that PFT is structurally stronger than in past cycles, better able to protect profitability even as chemical and certain regional markets remain weak.
Strong Cash Generation and Ample Balance-Sheet Flexibility
Crane reported adjusted free cash conversion of 102% for 2025, reinforcing the company’s reputation as a strong cash generator. Net leverage stood at about 1.1x after the Druck, Panametrics, and Reuter-Stokes deals and rose to roughly 1.4x after closing optek-Danulat—still in a comfortable range. Management stressed that this leaves room for additional M&A while supporting organic investment, suggesting a continued balanced approach to capital deployment.
Strategic Acquisitions Already Tracking Better Than Expected
The company closed several notable acquisitions—Druck, Panametrics, Reuter-Stokes (all as of January 1) and optek-Danulat—bolstering its portfolio in measurement, sensing, and process technologies. Reuter-Stokes doubles the size of Crane’s nuclear business, deepening exposure to an attractive long-cycle market. Importantly, management now expects these acquisitions to be slightly accretive to 2026 earnings, an upgrade from the prior view of essentially no accretion, indicating early integration progress and confidence in synergy realization.
Updated Non-GAAP Framework and 2026 EPS Outlook
Crane introduced a refined non-GAAP presentation, starting in 2026, that will exclude tax-effected acquisition-related intangible amortization from adjusted EPS, aligning its reporting more closely with peers. Against this backdrop, the company guided to 2026 adjusted EPS of $6.55 to $6.75, implying about 10% growth at the midpoint after normalizing for the $0.16 hurricane insurance benefit in 2025. The updated framework should make comparisons more straightforward for investors, especially as Crane becomes more acquisitive.
Segment Wins Underscore Competitive Positioning
The call highlighted a series of noteworthy contract wins, reinforcing Crane’s competitive positioning across end markets. In AAT, the company secured follow-on orders for F-16 brake control and additional defense vehicle programs, supporting the strong defense backlog. In PFT, Crane notched wins in cryogenics tied to space launch customers, pharmaceutical applications including GLP-1 capacity buildouts, and targeted chemical projects in the Middle East. These wins point to attractive niches where Crane’s technology and domain expertise are resonating.
PFT Orders and Backlog Reflect Chemical Market Trough
Despite good margin control, PFT’s demand indicators showed strain. Core FX-neutral backlog in PFT fell 7% year over year, and core FX-neutral orders declined about 3%, while core sales were down 1.5% in the quarter. Management characterized this as a cyclical trough driven largely by weakness in chemical markets. While not yet turning, this softness appears well understood and is being managed through cost actions and disciplined pricing rather than aggressive discounting.
Acquisitions to Dilute Margins Near Term but Build Earnings Power
Management was upfront that newly acquired businesses—Druck and the PFT assets Panametrics, Reuter-Stokes, and optek—will be dilutive to segment margins in the near term. Integration work, overlapping costs, and the inherent margin profiles of the acquired units will weigh on reported segment profitability even as they contribute to revenue and longer-term earnings. The company’s stance is that accepting short-term margin dilution is worthwhile to secure attractive strategic positions and build scale in higher-value niches.
Non-Recurring Insurance Benefit Creates Tougher Comparisons
The 2025 results included $9 million of hurricane-related insurance recoveries, which boosted adjusted EPS by $0.16. Management emphasized that this benefit will not recur in 2026, creating a small but real headwind for year-over-year comparability. By calling this out explicitly, Crane is attempting to set realistic expectations and ensure investors adjust their models for this one-time tailwind.
Seasonally Soft and Integration-Heavy Start to 2026
Crane expects the first quarter of 2026 to be seasonally soft and roughly flat compared with Q1 2025. The subdued start to the year will be amplified by integration work on the newly acquired assets and by higher interest expense. The acquired businesses also tend to be stronger in the second half, so the company is planning for a weighted earnings profile of roughly 45% in the first half and 55% in the second half of 2026, signaling a back-half ramp.
Higher Interest Costs and Slightly Elevated Tax Rate
Funding the recent acquisitions will push 2026 interest expense to around $58 million, a noticeable increase versus prior periods. At the same time, management expects the effective tax rate to tick up to about 23%. While neither factor is dramatic on its own, together they create modest pressure on net income growth and are important inputs for investors modeling Crane’s post-acquisition earnings power.
Regional and End-Market Headwinds, Especially in Chemicals
Chemical end markets remain a weak spot, particularly in Europe, China, and parts of Asia Pacific. Management expects PFT demand to be flat to low single-digit in 2026 as these regions work through the trough. While this is a drag on top-line growth, Crane’s strong performance in aerospace, nuclear, and specialized flow applications helps offset the softness, and the company appears content to prioritize margins over chasing lower-quality chemical volume.
Integration and Corporate Costs to Stay in Focus
Integration-related costs tied to IT, finance, and HR systems will remain an ongoing feature as Crane fully beds in its carve-out acquisitions. Some of these expenses will be excluded from adjusted results, but other recurring investments and hiring will flow through, pressuring near-term reported metrics. Corporate expense was $87 million in 2025, slightly above prior expectations due to M&A activity, and is guided to $80–85 million in 2026, though further deal-making could push it toward the high end of that range.
Forward-Looking Guidance Emphasizes Steady Growth and Discipline
For 2026, Crane is guiding to adjusted EPS of $6.55–$6.75, implying roughly 10% growth at the midpoint after adjusting for the non-recurring insurance benefit in 2025 and under a refined non-GAAP framework that excludes acquisition-related intangible amortization. Management reiterated a 4%–6% core sales growth baseline, expecting AAT at the high end of that range and PFT flat to low single-digit as chemical markets stabilize. Targeted core operating leverage is 35%–40% in AAT and 30%–35% in PFT, with a seasonally soft first quarter and earnings weighted toward the second half (about 45% in H1 and 55% in H2). Guidance also incorporates about $58 million in interest expense, a ~23% tax rate, and corporate expense of $80–85 million, all while maintaining balance-sheet flexibility after 102% adjusted free cash conversion in 2025 and leverage of roughly 1.4x post-acquisitions.
In summary, Crane’s earnings call painted the picture of a company leveraging strong aerospace momentum, disciplined execution and targeted acquisitions to drive double-digit earnings growth, even as chemical markets and integration costs create near-term friction. The growing backlog, resilient margins, and improving outlook for newly acquired businesses are key positives for investors, while higher interest expense, regional softness and margin dilution from acquisitions remain watch items. Overall, management’s confident tone and clear guidance suggest Crane is well positioned to navigate current headwinds and deliver steady value creation.
